Abbas Salmani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abbas Salmani has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad-Rafi Bazrafshan
Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran
2 shared publications - Ahmad Jabrodini
Department of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
1 shared publication - Amir Mansouri
Department of Paramedical School, Gerash University of Medical Sciences, Gerash, Iran
1 shared publication - Behnam Masmouei
School of Nursing Hazrat Zahra (P.B.U.H) Abadeh Shiraz University of Medical Sciences Shiraz Iran
1 shared publication - Esmaeil Kavi
Larestan University of Medical Sciences
1 shared publication - Fouziyeh Faraji
School of Nursing, Gerash University of Medical Sciences, Gerash, Iran
1 shared publication
Latest Publications
- 21 May 2024
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 30 (4) , 526-532
Explaining factors contributing to alcohol consumption among elderly men: a qualitative study
- 21 May 2024
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 30 (4) , 526-532
Explaining factors contributing to alcohol consumption among elderly men: a qualitative study
- Open Access
- 19 August 2023
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 25 (4)
Evaluating the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Medical and Administrative Staff at Gerash University of Medical Sciences
Background: In late 2019, a new virus spread in China that led to an acute respiratory disease by lung involvement. The virus spread over time and affected many countries, including Iran. Hospital staff are also at high risk of being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objectives: The present study aimed to evaluate the seroprevalence of IgG class antibodies against SARS-CoV-2 in healthcare workers and to compare the risk of SARS-CoV-2 infection in coronavirus disease 2019 (COVID-19) ward staff with other hospital wards. Methods: This cross-sectional study was conducted on medical staff at Gerash University of Medical Sciences. After sampling the participants in this study, the production of anti-SARS-CoV-2 IgG antibodies was evaluated using the enzyme-linked immunosorbent assay (ELISA) method. Demographic and other necessary information about patients were also recorded. Results: Out of 323 staff participating in this study, 130 (40.24%) were in inpatient wards [of which 26 (20%) were in the COVID-19 ward], 55 (17.02%) were in paraclinical wards, and 138 (42.72%) were in administrative wards. A total of 44 (13.6%) patients had anti-SARS-CoV-2 IgG antibodies. There was no significant difference in the prevalence of antibodies between the three groups, but a significantly higher prevalence of antibodies was observed in the COVID-19 ward subgroup with 6 (23%) positive antibody tests, compared to other wards (P-value = 0.023). Conclusions: Due to the higher prevalence of anti-SARS-CoV-2 IgG antibodies in staff working in the COVID-19 ward than in other wards, more attention should be paid to health protocols and also emphasis on completing vaccination and monitoring the safety level of staff working in the COVID-19 ward.
- 19 August 2023
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 25 (4)
Open AccessEvaluating the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Medical and Administrative Staff at Gerash University of Medical Sciences
Background: In late 2019, a new virus spread in China that led to an acute respiratory disease by lung involvement. The virus spread over time and affected many countries, including Iran. Hospital staff are also at high risk of being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objectives: The present study aimed to evaluate the seroprevalence of IgG class antibodies against SARS-CoV-2 in healthcare workers and to compare the risk of SARS-CoV-2 infection in coronavirus disease 2019 (COVID-19) ward staff with other hospital wards. Methods: This cross-sectional study was conducted on medical staff at Gerash University of Medical Sciences. After sampling the participants in this study, the production of anti-SARS-CoV-2 IgG antibodies was evaluated using the enzyme-linked immunosorbent assay (ELISA) method. Demographic and other necessary information about patients were also recorded. Results: Out of 323 staff participating in this study, 130 (40.24%) were in inpatient wards [of which 26 (20%) were in the COVID-19 ward], 55 (17.02%) were in paraclinical wards, and 138 (42.72%) were in administrative wards. A total of 44 (13.6%) patients had anti-SARS-CoV-2 IgG antibodies. There was no significant difference in the prevalence of antibodies between the three groups, but a significantly higher prevalence of antibodies was observed in the COVID-19 ward subgroup with 6 (23%) positive antibody tests, compared to other wards (P-value = 0.023). Conclusions: Due to the higher prevalence of anti-SARS-CoV-2 IgG antibodies in staff working in the COVID-19 ward than in other wards, more attention should be paid to health protocols and also emphasis on completing vaccination and monitoring the safety level of staff working in the COVID-19 ward.